| Product Code: ETC9963334 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States continues to rely on imports for contraceptive drugs and devices, with key suppliers in 2024 including Denmark, Israel, Ireland, Austria, and Mexico. The market shows moderate concentration as indicated by the HHI, with a steady growth trajectory reflected in the compound annual growth rate (CAGR) of 5.65% from 2020 to 2024. The growth rate for 2023-24 at 3.19% suggests a sustained demand for these products, highlighting the importance of international trade partnerships in meeting the contraceptive needs of the US population.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Contraceptive Drugs and Devices Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Contraceptive Drugs and Devices Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Contraceptive Drugs and Devices Market - Industry Life Cycle |
3.4 United States (US) Contraceptive Drugs and Devices Market - Porter's Five Forces |
3.5 United States (US) Contraceptive Drugs and Devices Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.6 United States (US) Contraceptive Drugs and Devices Market Revenues & Volume Share, By Gender, 2021 & 2031F |
4 United States (US) Contraceptive Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about family planning and contraception methods |
4.2.2 Rising prevalence of sexually transmitted infections (STIs) leading to higher demand for contraceptives |
4.2.3 Growing emphasis on women's health and empowerment |
4.3 Market Restraints |
4.3.1 Stringent regulations and policies surrounding contraceptive drugs and devices |
4.3.2 Limited access to contraceptives in certain regions or communities |
4.3.3 Concerns about potential side effects and health risks associated with some contraceptive methods |
5 United States (US) Contraceptive Drugs and Devices Market Trends |
6 United States (US) Contraceptive Drugs and Devices Market, By Types |
6.1 United States (US) Contraceptive Drugs and Devices Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Contraceptive Drugs and Devices Market Revenues & Volume, By Products, 2021- 2031F |
6.1.3 United States (US) Contraceptive Drugs and Devices Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.4 United States (US) Contraceptive Drugs and Devices Market Revenues & Volume, By Devices, 2021- 2031F |
6.2 United States (US) Contraceptive Drugs and Devices Market, By Gender |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Contraceptive Drugs and Devices Market Revenues & Volume, By Male, 2021- 2031F |
6.2.3 United States (US) Contraceptive Drugs and Devices Market Revenues & Volume, By Female, 2021- 2031F |
7 United States (US) Contraceptive Drugs and Devices Market Import-Export Trade Statistics |
7.1 United States (US) Contraceptive Drugs and Devices Market Export to Major Countries |
7.2 United States (US) Contraceptive Drugs and Devices Market Imports from Major Countries |
8 United States (US) Contraceptive Drugs and Devices Market Key Performance Indicators |
8.1 Percentage increase in the adoption rate of long-acting reversible contraceptives (LARCs) |
8.2 Number of new product innovations and technological advancements in the contraceptive market |
8.3 Rate of usage of telemedicine services for contraceptive consultations and prescriptions. |
9 United States (US) Contraceptive Drugs and Devices Market - Opportunity Assessment |
9.1 United States (US) Contraceptive Drugs and Devices Market Opportunity Assessment, By Products, 2021 & 2031F |
9.2 United States (US) Contraceptive Drugs and Devices Market Opportunity Assessment, By Gender, 2021 & 2031F |
10 United States (US) Contraceptive Drugs and Devices Market - Competitive Landscape |
10.1 United States (US) Contraceptive Drugs and Devices Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Contraceptive Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |